GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Institutional Ownership

Apex Biotechnology (TPE:1733) Institutional Ownership : 1.69% (As of Jun. 10, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Apex Biotechnology's institutional ownership is 1.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Apex Biotechnology's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Apex Biotechnology's Float Percentage Of Total Shares Outstanding is 0.00%.


Apex Biotechnology Institutional Ownership Historical Data

The historical data trend for Apex Biotechnology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Institutional Ownership Chart

Apex Biotechnology Historical Data

The historical data trend for Apex Biotechnology can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 1.31 1.26 1.26 1.26 1.34 1.43 1.49 1.67 1.69 1.69

Apex Biotechnology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Apex Biotechnology (TPE:1733) Business Description

Traded in Other Exchanges
N/A
Address
No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines